OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
17 mars 2025 10h32 HE
|
ORGANOX LIMITED
OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
24 févr. 2025 10h10 HE
|
ORGANOX LIMITED
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
12 nov. 2024 08h00 HE
|
ORGANOX LIMITED; eGenesis, Inc.
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
OrganOx metra® System Approved for Liver Transplantation in Canada
02 oct. 2024 08h15 HE
|
ORGANOX LIMITED
OrganOx metra® System Approved for Liver Transplantation in Canada
Appointment of Stephen M. Deitsch as new Chief Financial Officer
04 avr. 2024 11h43 HE
|
ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
OrganOx Raises £25 Million in Growth Round Led by Lauxera Capital Partners
17 juil. 2023 02h05 HE
|
ORGANOX LIMITED
OXFORD, United Kingdom, July 17, 2023 (GLOBE NEWSWIRE) -- OrganOx Ltd (“OrganOx” or the “Company”), a world-leading medical technology company committed to making every donated organ count with...